Quick Facts Flashcards
Pheo w/up:
- Spot plasma or urine metanephrine (sensitive)
- 24-urine metanephrine (specific)
- CT (> MRI)
- MIBG (if suspect multi-focal)
Mucinous cystic neoplasm - dx and tx
- dx: EUS-FNA w/ high CEA (>190), low Amylase
- tx: resect
Tx pelvic fx
- Binder
- Angio OR packing w/ fixation (especially if IR n/a)
- Early external fixation
- refractory bleed after angio → packing + fixation
**MC source is presacral venous plexus
Dx and Localize a gastrinoma
Dx:
1. Off PPI: G > 1000 or >200 w/ secretin stimlation
2. Can’t get off PPI: SS Scintigraphy
Localize:
1. Triphasic CT/MRI
2. SS Scintography (Dotatate PET/CT)
3. Endoscopic US
4. Selective intra arterial Ca
5. OR: Intra-Op US, transduodenal palpation, duodenotomy, palpate HOP
Tx pseudocyst/WON
Dx: US or CT
- if can’t r/o cystic neoplasm on imaging must get EUS-FNA
Tx: drain if persistent sxs. Wait 4-6 weeks for the wall to mature
- near stomach/duo, > 6cm: endoscopic cystogastrostomy/duodenostomy
- open or lap cysto-enterostomy (usually jejunostomy if not abutting duo or stomach)
Tx of pancreatitis masses
1. WON sterile
2. WON infected
3. Pseudocyst
4. Infected pseudocyst
- WON sterile: conservatively
- WON infected: step-up approach
- Pseudocyst: tx if sxs (infxn, obstruction, pain)
- 4-6w → internal drain → cyst-enterostomy - Infected pseudocyst: drainage (internal, external, endoscopic). Endoscopic preferred.
Indications to tx ICA stenosis and sxs
- Asx: > 60%
- Sxs: > 50% (>125 cm/s)
- Sxs: contralateral motor/sensory sxs, ipsi vision sxs
Bethesda criteria for thyroid
**1 cm is cutoff to get an FNA
- Non-diagnostic → repeat FNA
- Benign → follow-up
- Undetermined significance → repeat FNA or lobectomy
- Follicular neoplasm → lobectomy
- Suspicious for malignancy → lobectomy vs. thyroidectomy
- Malignant → thyroidectomy
Achalasia - Px, Dx, Path and Tx
Px: dysphagia (to solid and liquid) is MC sx
Dx:
- no peristalsis
- high LES pressure > 15 (vs. scleroderma, low)
- incomplete relaxation
Path: injured ganglion cells
Tx: only motility disorder w/ upfront surgery
- myotomy (6 eso, 2 stomch) is 1st line (avoid Nissen).
- botox or dilation if high risk.
Tx Medullary thyroid cancer
- TOTAL thyroidectomy
- > 1 cm or bilobar: bilateral central/level 6 dissection
- Lateral neck dissection on that side if central+
- Start T4 postop. Monitor w/ calcitonin AND CEA
- RAI is c/i! (C cell origin)
Radial scar- Dx and Tx
- Dx: aka comlpex sclerosing lesion
- Mammo: spiculated mass with central sclerosis (lucency) and surrounding distortion
- Histo: fibroelastic core w/ entrapped ducts
Gross: white center (central scar) - Tx: core bx ➡ excisional bx (to r/o ca)
Tx mucinous neoplasm of the appendix
- Confined to appendix: appe only (no LADN’y)
- must have negative margin
- scope in 6w to r/o sync lesions - Involving base, ruptured, or +margin: R hemi +/- LADN
- Peritoneal dissemination: perc bx
- if appendicitis: remove ruptured segment + directed peritoneal bx
- no appendicitis: postpone appe until cytoreductive surgery
- no hipec/cancer operation until staged
**need post-op scope to r/o synchronous lesions
When to excise burns
- < 72 hours but not until after appropriate fluid resuscitation
- Used for deep 2nd-, 3rd-, and some 4th-degree burns
- Viability is based on punctate bleeding (#1), color, and texture after removal (use dermatome)
Liver lesions on arterial phase:
HCC
Mets
Adenoma
Hemangioma
FNH
- HCC: rapid enhancement. rapid w/out. “hot” on nuclear imaging
- Mets: Hypoattenuation
- Adenoma: rapid enhancement. rapid w/out. “cold” on nuclear imaging. gado/eovist not retained
- Hemangioma: peripheral nodular enhancement. delay: centripetal fill-in (no early washout!)
- FNH: Centrifugal enhancing. w/out except for scar enhancement. take up sulfer colloid and gado/eovist
Elective surgery after stent
- ASA lifelong
- Plavix
- BMS: 1 month
- DES: 6 months (ideally). Can be 1 month if needed for urgent surgery (cancer)
Teg interpretation:
R time
K time
a angle
MA
LY 30
R time- FFP
K time- cryo
a angle- cryo
MA- PLTs
LY 30- TXA
Rule of 6’s:
R > 6 minutes
alpha angle > 60 degrees
MA < 60 mm
LY30 > 6%
Tx and Survival Benefit of ARDS
- TV at 4-6 ml/kg
- Permissive hypercapnia
- Proven benefit: prone, lung protection, paralyze
-P/F < 100 = severe
Glucagonoma - loc, px, dx, tx
Loc: distal (a cells)
Px: dermatitis, DRH, DM, nec mig erythema
- most malignant
- no stones (vs. SS’oma)
Dx: gluc > 1000
Tx: distal panc + splenectomy + LADN’y + CC’y
z11 trial implications
- If less than 3 nodes positive on SLN and T1 or T2 disease, BCT is OK
- if >70, t1, ER+ and SNLBx neg ➡ can consider no XRT after lumpectomy
Hard signs of vascular injury
shock
expanding hematoma
pulsatile bleed
thrill/bruit
absent pulse
ischemia
If negative ➡ ABI…if positive ➡ CTA (to localize)
Polyps that require surgery instead of endoscopic resection
- Submucosal invasion > 1mm
- Poorly differentiated
- <1 mm margin
- LV invasion
- Tumor budding
- Taken piecemeal
T staging indications for neoadjuvant
- eso
- stomach
- colon
- rectal
- lung
- eso: T2 (MP)
- stomach: t2 (MP)
- colon: t4b (adjacent organs)
- rectal: t3 (through MP)
- lung: n2 nodes
Screening in IBD patients
- Start 8 years after sx onset
- 2-4 random bx every 10 cm throughout the colon + suspicious areas
Repeat schedule:
- normal: q1-3 years
- PSC, stricture, or dysplasia w/out colectomy: q1 year
Any dysplasia usually gets a colectomy
- if resectable can consider endoscopic resection with close surveillance
NEC - px and tx
Px: bloody stools after 1st feed
- prematurity is biggest RF
tx:
- resuscitation, ngt, abx (no surgery) x 7-10 day (50% success)
-surgery (50%): resect all non-viable segments. create stoma.